A new method of constructing “ArSCF 2 CF 2 Cu” from ArSCu and TMSCF 2 Br (TMS=trimethylsilyl) has been developed. The cross‐coupling reactions of the obtained “ArSCF 2 CF 2 Cu” with diverse aryl iodides (Ar′I) provide an efficient access to Ar′CF 2 CF 2 SAr. Mechanistic studies demonstrate that the “ArSCF 2 CF 2 Cu” species were generated through controllable double difluoromethylene insertions into ArS−Cu bonds rather than the 1,2‐addition of ArSCu to tetrafluoroethylene.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: